Hematogenix
Jingjing Guo is an experienced professional in the field of clinical biomarker research and operations management. Currently serving as the Manager of Operations in China for Hematogenix since September 2019, Jingjing Guo leads clinical biomarker central lab services for multiple global clinical trials, oversees biomarker assay transfer and training, and facilitates business development and facility establishment in the Chinese market. Prior to this role, Jingjing Guo held the position of Associate Director of Translational Medicine at 上海观合医药科技有限公司, where responsibilities included leading clinical biomarker research for domestic and global trials and establishing new technology platforms. With previous experience as a scientist at both 葛兰素史克公司 and 上海睿智化学研究有限公司, Jingjing Guo has contributed to numerous projects across various therapeutic areas. Jingjing Guo holds a Ph.D. in Molecular Pharmacology and a Bachelor's degree in Pharmacy from China Pharmaceutical University.
This person is not in any offices
Hematogenix
1 followers
Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant